No information given. View more info. Currently Online. Badges 9 Games 13 Inventory Groups 2 Hentai! 1,076,864 Members. SAPIC 5,878 Members. Friends 25 113.
- Olmed vaxjo
- Kollaps raf simons
- Jobba på postnord lön
- Den magiska trädgården
- Brittiska ambassaden stockholm
Visa ACARIX AB-diagram live för att se aktiens kursutveckling. Hitta marknadsprognoser, finansiella ACARIX-data och marknadsnyheter. Acarix AB. Organisationsnummer 559009-0667. Namnändringar och notering på lista. År. Kommentarer.
1 vecka. Acarix AB operates as a medical technology company which is engaged in developing diagnostic tests for cardiovascular diseases primarily in Europe, China, and the United States.
Acarix is a medical technology company marketing the CADScor®System, currently available in Sweden, Denmark and Germany. The CADScor®System is developed from pioneering research on phonocardiography, providing an innovative, non-invasive and ultra-sensitive analytical diagnostic aid for immediate rule-out. Acarix. SMA (Simple Moving Average), eller Glidande Medelvärde, visar det genomsnittliga värdet historiskt för det intervall du väljer.
Vid misstänkt kranskärlsjukdom används CAD-Score för att ge en poäng mellan 0 till 99. Om patienten har lägre än 20 poäng så är sannolikheten för hjärtsjukdom låg.
Synalar otico
Klik her for at følge aktiekursen i realtid Acarix has 531 members. Denna grupp är till för alla som är aktieägare i Acarix, alternativt de som har ett seriöst intresse att investera i Acarix.
The Company produces a system for the early diagnosis of coronary artery disease based on recording of acoustic
Acarix, a Swedish company, sells the CE-marked CADScor to enable about half of chest-pain patients with suspected coronary artery disease to be ruled out from further, expensive testing. 2 Mkt Cap indicates the market value of the selected share series admitted to trading on Nasdaq Nordic. Note that the company may have other share series admitted to trading and that it may have unlisted shares. Acarix is a company that develops medical devices for the treatment of coronary artery disease (CAD).
Vygotskij utvecklingszon
plusgymnasiet malmö
bauhaus göteborg
norrbro lammas
linas matkasse karlskrona
ifmetall mina sidor
- Johannes lindvall lunds universitet
- Normativ social påverkan
- Trollhättan källstorp vårdcentral
- Tandsköterskor utbildning
- Apache hadoop ecosystem
- Tecknade snygga bilder
With Prevas as a developer partner. With the Acarix CADScor®System we are seeing growth in an entirely new and advanced medical technology – difficult to Acarix was established in 2009 as a spin-out from Coloplast A/S and is a company that develops and markets cardiology diagnostic products. The company was Acarix is a medical technology company marketing the CADScor®System, currently available in Sweden, Denmark and Germany.
1,660. Utvikling i dag. +3,88%. +0,062. Kjøp. 1,648.
It develops and commercializes diagnostic tests based on its technology platform CADScor System. The company was founded by Peter Boman Samuelsen, Samuel Schmidt, Weimin Rong and Claus Bo Vöge Christensen in 2009 and is headquartered in Malmo, Sweden. Acarix AB operates as a medical technology company which is engaged in developing diagnostic tests for cardiovascular diseases primarily in Europe, China, and the United States. Its main activities are to develop, produce and market a new cardiovascular diagnostic method and similar equipment for the same and related services. Description: Acarix A/S is based on pioneering research performed at the Aalborg University, Denmark, initiated in 2004. The CADScor system is designed to significantly decrease the cost of the Coronary Artery Disease diagnostic pathway by lowering the evaluation cost. Acarix was established in 2009 and is listed on Nasdaq First North Premier Growth Market (ticker: ACARIX).